Avichai Shimoni

10.1k total citations · 1 hit paper
252 papers, 6.9k citations indexed

About

Avichai Shimoni is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Avichai Shimoni has authored 252 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Hematology, 86 papers in Oncology and 48 papers in Genetics. Recurrent topics in Avichai Shimoni's work include Hematopoietic Stem Cell Transplantation (130 papers), Acute Myeloid Leukemia Research (81 papers) and Acute Lymphoblastic Leukemia research (44 papers). Avichai Shimoni is often cited by papers focused on Hematopoietic Stem Cell Transplantation (130 papers), Acute Myeloid Leukemia Research (81 papers) and Acute Lymphoblastic Leukemia research (44 papers). Avichai Shimoni collaborates with scholars based in Israel, United States and Germany. Avichai Shimoni's co-authors include Arnon Nagler, Ronit Yerushalmi, Noga Shem‐Tov, Abraham Avigdor, Izhar Hardan, Ivetta Danylesko, Moshe Yeshurun, Michal J. Besser, Maya Koren‐Michowitz and Merav Leiba and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Avichai Shimoni

243 papers receiving 6.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies

2008 536 citations Abraham Kneller, Merav Leiba et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Avichai Shimoni Israel	41	3.6k	2.9k	2.1k	1.1k	1.1k	252	6.9k
Álvaro Urbano-Ispizúa Spain	44	3.3k 0.9×	1.7k 0.6×	2.3k 1.1×	748 0.7×	819 0.8×	215	6.1k
Frédéric Baron Belgium	40	5.2k 1.5×	1.7k 0.6×	1.9k 0.9×	1.4k 1.3×	759 0.7×	220	7.2k
David B. Miklos United States	37	2.1k 0.6×	2.2k 0.8×	2.6k 1.2×	590 0.5×	1.5k 1.4×	224	6.5k
Chitra Hosing United States	51	5.1k 1.4×	3.2k 1.1×	2.2k 1.0×	1.2k 1.0×	1.3k 1.2×	372	8.9k
Renato Fanin Italy	42	3.6k 1.0×	2.0k 0.7×	1.2k 0.6×	705 0.6×	1.4k 1.3×	226	6.6k
Kirk R. Schultz Canada	45	5.0k 1.4×	1.3k 0.5×	1.8k 0.9×	2.6k 2.3×	770 0.7×	214	7.4k
Wing Leung United States	49	3.8k 1.1×	2.9k 1.0×	3.5k 1.7×	1.8k 1.6×	999 0.9×	206	8.0k
Joseph O. Moore United States	42	3.3k 0.9×	1.9k 0.7×	962 0.5×	1.2k 1.1×	1.8k 1.7×	148	6.6k
Jamie Cavenagh United Kingdom	40	4.6k 1.3×	1.9k 0.6×	1.8k 0.9×	534 0.5×	2.5k 2.4×	141	6.7k
Matthias Theobald Germany	37	2.4k 0.7×	2.2k 0.8×	2.4k 1.2×	664 0.6×	1.7k 1.6×	145	5.9k

Countries citing papers authored by Avichai Shimoni

Since Specialization

Citations

This map shows the geographic impact of Avichai Shimoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avichai Shimoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avichai Shimoni more than expected).

Fields of papers citing papers by Avichai Shimoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avichai Shimoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avichai Shimoni. The network helps show where Avichai Shimoni may publish in the future.

Co-authorship network of co-authors of Avichai Shimoni

This figure shows the co-authorship network connecting the top 25 collaborators of Avichai Shimoni. A scholar is included among the top collaborators of Avichai Shimoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avichai Shimoni. Avichai Shimoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koreth, John, Jeremy Pantin, Shukaib Arslan, et al.. (2025). Primary results from Equator, a Phase 3 double-blind, randomized placebo-controlled study evaluating itolizumab in combination with corticosteroids as initial treatment of acute graft-versus-host disease.. Blood. 146(Supplement 1). 274–274.

Shouval, Roni, Shalev Fried, Ivetta Danylesko, et al.. (2025). Pretreatment pulmonary function testing has limited utility in B-cell lymphoma treated with CD19 CAR T cells. Blood Advances. 9(7). 1720–1725. 1 indexed citations

Danylesko, Ivetta, Noga Shem‐Tov, Ronit Yerushalmi, et al.. (2024). Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression. Current Research in Translational Medicine. 72(4). 103471–103471. 5 indexed citations

Youngster, Ilan, Ivetta Danylesko, Israel Henig, et al.. (2024). Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study. Bone Marrow Transplantation. 59(3). 409–416. 7 indexed citations

Shimoni, Avichai, Christophe Peczynski, Myriam Labopin, et al.. (2024). Post-transplant cyclophosphamide separates graft-versus host disease and graft versus leukemia effects after HLA-matched stem-cell transplantation for acute myeloid leukemia. Leukemia. 39(1). 222–228. 2 indexed citations

Danylesko, Ivetta, Noga Shem‐Tov, Ronit Yerushalmi, et al.. (2023). P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION. HemaSphere. 7(S3). e4369964–e4369964. 1 indexed citations

Magen, Hila, Shalev Fried, Orit Itzhaki, et al.. (2023). POINT‐OF‐CARE ANTI‐BCMA CAR T‐CELL THERAPY INDUCES ENCOURAGING RESPONSE RATES IN HIGH‐RISK RELAPSED/REFRACTORY MULTIPLE MYELOMA. Hematological Oncology. 41(S2). 82–83. 1 indexed citations

Fried, Shalev, Ivetta Danylesko, Orit Itzhaki, et al.. (2023). High Response Rates Following Point-of-Care Anti-CD19 CAR T-Cell Therapy in Adults with Relapsed/Refractory Acute B Lymphoblastic Leukemia. Blood. 142(Supplement 1). 6875–6875.

Kedmi, Meirav, Roni Shouval, Shalev Fried, et al.. (2022). Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphoma. Transplantation and Cellular Therapy. 28(5). 251–257. 24 indexed citations

10.

Danylesko, Ivetta, Roni Shouval, Noga Shem‐Tov, et al.. (2020). Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphoma. Bone Marrow Transplantation. 56(5). 1134–1143. 23 indexed citations

11.

Beider, Katia, Avichai Shimoni, Merav Leiba, et al.. (2016). The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway. Clinical Cancer Research. 23(7). 1733–1747. 33 indexed citations

12.

Shouval, Roni, Myriam Labopin, Ron Unger, et al.. (2016). Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study. PLoS ONE. 11(3). e0150637–e0150637. 31 indexed citations

13.

Shouval, Roni, Myriam Labopin, Avichai Shimoni, et al.. (2015). Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study. Journal of Clinical Oncology. 33(28). 3144–3151. 105 indexed citations

14.

Danylesko, Ivetta, Nira Varda‐Bloom, Ronit Yerushalmi, et al.. (2015). Plerixafor (Mozobil): A Stem Cell-Mobilizing Agent for Transplantation in Lymphoma Patients Predicted to Be Poor Mobilizers - A Pilot Study. Acta Haematologica. 135(1). 29–36. 8 indexed citations

15.

Avigdor, Abraham, Meirav Kedmi, Miriam Berkowicz, et al.. (2014). The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma. Annals of Hematology. 93(8). 1297–1304. 41 indexed citations

16.

Peled, Amnon, Michal Abraham, Irit Avivi, et al.. (2013). The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma. Clinical Cancer Research. 20(2). 469–479. 70 indexed citations

17.

Besser, Michal J., Ronnie Shapira‐Frommer, Orit Itzhaki, et al.. (2013). Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies. Clinical Cancer Research. 19(17). 4792–4800. 294 indexed citations

18.

Besser, Michal J., Ronnie Shapira‐Frommer, Avraham J. Treves, et al.. (2010). Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients. Clinical Cancer Research. 16(9). 2646–2655. 352 indexed citations

19.

Hardan, Izhar, Alain Gelibter, Ninette Cohen, et al.. (2004). Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis. Experimental Hematology. 32(3). 254–260. 13 indexed citations

20.

Champlin, Richard E., Issa F. Khouri, Paolo Anderlini, et al.. (2001). Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Bone Marrow Transplantation. 27(S2). S13–S22. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact